Endosphere is an award-winning clinical-stage medical technology innovator. The company has established a new category of less-invasive endoscopic technologies to improve patient outcomes in the world's largest and highest-growth healthcare category: Metabolic Diseases including obesity, fatty liver disease, and diabetes. Endosphere has built an IP asset portfolio of patented inventions developed by its R&D team led by Dr. Kenneth Binmoeller, the company’s founder and chief medical officer. Dr. Binmoeller is a recognized key opinion leader in gastroenterology, having published more than 200 papers and peer-reviewed articles. He is the Head of Endoscopy at California Pacific Medical Center and the former Director of Endoscopy at University of California-San Diego Medical School. Dr. Binmoeller’s prior company, Xlumena, was successfully acquired by Boston Scientific in 2015.
| Website | https://www.endo-sphere.com |
| Revenue | $4 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 2007 |
| Address | 4449 Easton Way Fl 2, Columbus, Ohio 43219, US |
| Phone | +1 614-245-0338 |
| Technologies | |
| Industry | Medical Equipment Manufacturing, Manufacturing General, Health Care, Therapeutic Devices, Manufacturing, Life Science, Biotechnology, Science and Engineering, Medical Device |
| Competitors | Johnson & Johnson, Medtronic, Abbott, Stryker, Cleveland Clinic, Boston Scientific, KARL STORZ GmbH & Co KG, Inspire Medical Systems, GI Dynamics, Hanson Medical Group +46 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular EndoSphere Inc. employee's phone or email?
EndoSphere Inc. Questions
The EndoSphere Inc. annual revenue was $4 million in 2026.
EndoSphere Inc. is based in Columbus, Ohio.
The NAICS codes for EndoSphere Inc. are [33, 339].
The SIC codes for EndoSphere Inc. are [38, 384].
